Cargando…
Fibroblasts in cancer dormancy: foe or friend?
Cancer dormancy is defined that the residual cancer cells could enter into a state of quiescence and patients remain asymptomatic for years or even decades after anti-tumor therapies. Fibroblasts, which represent a predominant cell type in tumor microenvironment, play a pivotal role in determining t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995785/ https://www.ncbi.nlm.nih.gov/pubmed/33771156 http://dx.doi.org/10.1186/s12935-021-01883-2 |
_version_ | 1783669980317876224 |
---|---|
author | Dai, Li Li, Mao Zhang, Wei-long Tang, Ya-Jie Tang, Ya-ling Liang, Xin-hua |
author_facet | Dai, Li Li, Mao Zhang, Wei-long Tang, Ya-Jie Tang, Ya-ling Liang, Xin-hua |
author_sort | Dai, Li |
collection | PubMed |
description | Cancer dormancy is defined that the residual cancer cells could enter into a state of quiescence and patients remain asymptomatic for years or even decades after anti-tumor therapies. Fibroblasts, which represent a predominant cell type in tumor microenvironment, play a pivotal role in determining the ultimate fate of tumor cells. This review recapitulates the pleiotropic roles of fibroblasts which are divided into normal, senescent, cancer-associated fibroblasts (CAFs) and circulation CAFs in tumor dormancy, relapse, metastasis and resistance to therapy to help the treatment of cancer metastasis. |
format | Online Article Text |
id | pubmed-7995785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79957852021-03-30 Fibroblasts in cancer dormancy: foe or friend? Dai, Li Li, Mao Zhang, Wei-long Tang, Ya-Jie Tang, Ya-ling Liang, Xin-hua Cancer Cell Int Review Cancer dormancy is defined that the residual cancer cells could enter into a state of quiescence and patients remain asymptomatic for years or even decades after anti-tumor therapies. Fibroblasts, which represent a predominant cell type in tumor microenvironment, play a pivotal role in determining the ultimate fate of tumor cells. This review recapitulates the pleiotropic roles of fibroblasts which are divided into normal, senescent, cancer-associated fibroblasts (CAFs) and circulation CAFs in tumor dormancy, relapse, metastasis and resistance to therapy to help the treatment of cancer metastasis. BioMed Central 2021-03-26 /pmc/articles/PMC7995785/ /pubmed/33771156 http://dx.doi.org/10.1186/s12935-021-01883-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Dai, Li Li, Mao Zhang, Wei-long Tang, Ya-Jie Tang, Ya-ling Liang, Xin-hua Fibroblasts in cancer dormancy: foe or friend? |
title | Fibroblasts in cancer dormancy: foe or friend? |
title_full | Fibroblasts in cancer dormancy: foe or friend? |
title_fullStr | Fibroblasts in cancer dormancy: foe or friend? |
title_full_unstemmed | Fibroblasts in cancer dormancy: foe or friend? |
title_short | Fibroblasts in cancer dormancy: foe or friend? |
title_sort | fibroblasts in cancer dormancy: foe or friend? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995785/ https://www.ncbi.nlm.nih.gov/pubmed/33771156 http://dx.doi.org/10.1186/s12935-021-01883-2 |
work_keys_str_mv | AT daili fibroblastsincancerdormancyfoeorfriend AT limao fibroblastsincancerdormancyfoeorfriend AT zhangweilong fibroblastsincancerdormancyfoeorfriend AT tangyajie fibroblastsincancerdormancyfoeorfriend AT tangyaling fibroblastsincancerdormancyfoeorfriend AT liangxinhua fibroblastsincancerdormancyfoeorfriend |